Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-02-26 @ 11:43 PM
Study NCT ID:
NCT02454634
Status:
COMPLETED
Last Update Posted:
2018-11-07
First Post:
2015-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas
Sponsor:
National Center for Tumor Diseases, Heidelberg
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-19
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-12
First Submit QC Date:
None
Study First Post Date:
2015-05-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-06
Last Update Post Date:
2018-11-07
Last Update Post Date Type:
ACTUAL